Partillion Bioscience Corp
Biotechnology company · Los Angeles, California, United States
Partillion Bioscience Corp is a biotechnology company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2020. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $5.1 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $4.9 million sold in a notice filed in 2022.
Partillion Bioscience at a glance
What does Partillion Bioscience do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $5.1 million in total (2021 to 2025). NIH funding came from the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.9 million sold (2022).
Frequently asked questions about Partillion Bioscience
Where is Partillion Bioscience headquartered?
Partillion Bioscience Corp is headquartered in Los Angeles, California, United States.
What does Partillion Bioscience do?
Partillion Bioscience Corp is a biotechnology company.
When was Partillion Bioscience founded?
The earliest incorporation on record for Partillion Bioscience Corp is in 2020, according to public company registers.
Similar companies
- LadRx CorpLos Angeles, California, United States
- Spinogenix, Inc.Los Angeles, California, United States
- Armata Pharmaceuticals, Inc.Los Angeles, California, United States
- Enspire Bio, Inc.Los Angeles, California, United States
- Clarus Therapeutics Holdings, Inc.Los Angeles, California, United States
- Amydis, Inc.Los Angeles, California, United States
- Uplifting Results Labs, Inc.Los Angeles, California, United States
- Paralos Bioscience Inc.Los Angeles, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences